- Home
- PTGX vs TENB Comparison
PTGX vs TENB Comparison
Compare PTGX & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | TENB |
|---|---|---|
| Founded | 2006 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 3.5B |
| IPO Year | 2016 | 2018 |
Fundamental Metrics
Financial Performance| Metric | PTGX | TENB |
|---|---|---|
| Price | $89.29 | $26.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 17 |
| Target Price | ★ $86.44 | $39.25 |
| AVG Volume (30 Days) | 898.7K | ★ 1.1M |
| Earning Date | 11-06-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | $209,217,000.00 | ★ $974,603,000.00 |
| Revenue This Year | N/A | $12.22 |
| Revenue Next Year | $296.47 | $7.62 |
| P/E Ratio | $124.48 | ★ N/A |
| Revenue Growth | N/A | ★ 11.05 |
| 52 Week Low | $33.70 | $25.28 |
| 52 Week High | $93.25 | $45.45 |
Technical Indicators
Market Signals| Indicator | PTGX | TENB |
|---|---|---|
| Relative Strength Index (RSI) | 64.67 | 40.17 |
| Support Level | $83.52 | $26.24 |
| Resistance Level | $90.85 | $27.07 |
| Average True Range (ATR) | 2.63 | 0.65 |
| MACD | -0.33 | 0.13 |
| Stochastic Oscillator | 83.62 | 46.91 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About TENB Tenable Holdings Inc.
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.